• Research Updates

    Signet cell histology: poor prognostic factor in peritoneal cancer

    Some patients with colorectal cancer are diagnosed with a specific subtype: "signet-cell histology". Recent research has identified this subtype as a indicator for poor survival after HIPEC.

    Read more
  • Clinical trials in peritoneal metastases

    Trial information

    We welcome short descriptions of ongoing trials world-wide. Information may be sent to: info@HIPEC.com

    Read more
  • Research Updates

    Promising results for HIPEC in small bowel cancer

    Researchers from the Netherlands have shown that long-term survival may be achieved for patients suffering from peritoneal cancer with a small bowel origin by using cytoreductive surgery and HIPEC.

    Read more
  • Technical information

    Determining the Peritoneal Cancer Index

    The Peritoneal Cancer Index or “PCI” is used to assess the extent of the peritoneal cancer throughout the peritoneal cavity. For this purpose, the peritoneal cavity is divided in 13 well-defined regions (see figure). In each of the 13 regions the size of the largest tumor nodule is measured

    Read more
  • Events

    10th International Congress on Peritoneal Surface Malignancies

    The 10th International Congress on Peritoneal Surface Malignancies takes place on November 17 - 19th, 2016 in Washington, DC.

    Read more
  • Origin of peritoneal cancer

    Colorectal Origin

    Peritoneal cancer caused by a tumor in the colon or rectum is the most frequent type of peritoneal cancer in men and the second-most common type in women (after peritoneal cancer caused by ovarian cancer).

    Read more
  • Origin of peritoneal cancer

    Pseudomyxoma Peritonei (PMP)

    Pseudomyxoma peritonei (PMP) is a rare clinical condition that results from a mucus-producing tumor in the appendix. The medical term for such tumor is a “mucocele”, and it may be benign or malignant.

    Read more